Skip to main content
DNA
NYSE Life Sciences

Ginkgo Bioworks Q1 Revenue Plummets 49% to $19.5M Amid Continued Losses

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$8.564
Mkt Cap
$633.216M
52W Low
$5.37
52W High
$17.58
52W Position info
59% above low
Off High info
51% below high
Rel. Volume info
1.6× avg
Market data snapshot near publication time

DNA sits 59% above its 52-week low of $5.37.

Summary

Ginkgo Bioworks reported its first-quarter 2026 results, revealing a significant 49% year-over-year decline in revenue to $19.5 million. The company also posted a GAAP net loss from continuing operations of $(76.1) million and an Adjusted EBITDA loss of $(42.3) million. This earnings report provides the first look at the company's financial performance following the strategic divestiture of its Biosecurity business on April 3, 2026, a move previously outlined in its last 10-K. The substantial revenue contraction in its continuing operations is a material concern for investors, despite a slight narrowing of losses. Traders will be closely watching for signs of improved revenue growth and reduced cash burn, especially given the reiterated full-year cash burn guidance of $(150) million to $(125) million.

At the time of this announcement, DNA was trading at $8.56 on NYSE in the Life Sciences sector, with a market capitalization of approximately $633.2M. The 52-week trading range was $5.37 to $17.58. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

DNA - Latest Insights

DNA
Nov 09, 2026, 4:52 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $12.30
Real-time Price: $7.61 info
Change: -$4.69 (-38%) info
Market Cap: $483.595M info
DNA
Nov 05, 2026, 4:07 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $9.80
Real-time Price: $7.61 info
Change: -$2.19 (-22%) info
Market Cap: $483.595M info
DNA
Nov 05, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $9.95
Real-time Price: $7.61 info
Change: -$2.34 (-23%) info
Market Cap: $483.595M info
DNA
Aug 06, 2026, 4:09 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $8.50
Real-time Price: $7.61 info
Change: -$0.890 (-10%) info
Market Cap: $483.595M info
DNA
May 07, 2026, 4:13 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $9.05
Real-time Price: $7.61 info
Change: -$1.44 (-16%) info
Market Cap: $483.595M info